All Articles

Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting

The evolving role of contrast-enhanced ultrasound in hepatocellular carcinoma: from diagnosis to therapeutic monitoring

Application of ex vivo liver perfusion in hepatoma research

Converse therapeutic hierarchy in hepatocellular carcinoma

Molecular characteristics of fatty acid metabolic reprogramming in hepatocellular carcinoma and their implications for immunotherapy

Exploring the molecular pathology and tumor microenvironment in gastric cancer liver metastasis

Rewiring the tumor microenvironment in hepatocellular carcinoma: mechanism-driven integration of immunotherapy and locoregional strategies

Controlled attenuation parameter factors and steatosis grading in metabolic dysfunction-associated steatotic liver disease

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

Functional cure of chronic hepatitis B virus infection: current therapeutic regimens

A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in hepatocellular carcinoma patients receiving TACE plus immunotherapy

Artificial intelligence for enhancing decision-making in multidisciplinary tumor boards for HCC in China

The multiparametric therapeutic hierarchy: a multidisciplinary approach to HCC management

Thermal ablation therapy for hepatocellular carcinoma: recurrence mechanisms and intervention strategies

Immune microenvironment and immunotherapy strategies in MAFLD-related hepatocellular carcinoma

Price threshold analysis of biomarker surveillance for hepatocellular carcinoma in Australia

Oncolytic virus VG161 brings new hope for advanced HCC

The importance of patient fitness in expert and multidisciplinary multiparametric management of HCC: a narrative review